CIPLA 2022-10-12 Health serious FDA
Health · FDA · Recall #FDA-D-1550-2022
Arformoterol Tartrate Inhalation Solution, 15 mcg/2mL, 2 mL Sterile Unit-Dose Vial… Recall
Issued October 12, 2022 · CIPLA
In October 2022, CIPLA recalled the Arformoterol Tartrate Inhalation Solution, 15 mcg/2mL, 2 mL Sterile Unit-Dose Vial…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of Assurance of Sterility: environmental monitoring failure.
What you should do
- 1 Stop using Arformoterol Tartrate Inhalation Solution, 15 mcg/2mL, 2 mL Sterile Unit-Dose Vial… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact CIPLA to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- CIPLA
- Category
- Health
- Recall date
- October 12, 2022
- Units affected
- Not reported
- Sold at
- Product was distributed nationwide to distributors/wholesalers who may have further distributed the product.
- Recall number
- FDA-D-1550-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- CIPLA has 3 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.